CDL200Antibacterial Protein CDL200 Having Lytic Activity to Clostridioides difficile

摘要

The present invention is Clostridioides difficiledifficile ) relates to the antibacterial protein CDL200 having specific antibacterial activity against bacteria, and more particularly, the ability to specifically lyse Clostridioides difficile bacteria that can cause diseases by infecting animals including humans and Clostridioides difficile-specific antibacterial protein CDL200, characterized in that it comprises the amino acid sequence represented by SEQ ID NO: 1, and the Clostridioides difficile-specific antibacterial protein CDL200 as an active ingredient It relates to a pharmaceutical composition for the treatment of infections or diseases caused by Clostridioides difficile bacteria.